Positive News SentimentPositive NewsNYSE:AVNS Avanos Medical (AVNS) Stock Forecast, Price & News $20.34 +0.11 (+0.54%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$20.06▼$20.5350-Day Range$19.93▼$26.3152-Week Range$19.32▼$31.99Volume259,786 shsAverage Volume273,694 shsMarket Capitalization$953.34 millionP/E RatioN/ADividend YieldN/APrice Target$31.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Avanos Medical MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside52.4% Upside$31.00 Price TargetShort InterestHealthy1.89% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.61Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth44.86%From $1.07 to $1.55 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.42 out of 5 starsMedical Sector203rd out of 963 stocksSurgical Appliances & Supplies Industry7th out of 19 stocks 3.0 Analyst's Opinion Consensus RatingAvanos Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $31.00, Avanos Medical has a forecasted upside of 52.4% from its current price of $20.34.Amount of Analyst CoverageAvanos Medical has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.89% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently increased by 7.99%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 3.1 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 1.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Avanos Medical this week, compared to 3 articles on an average week.MarketBeat Follows2 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.90% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions93.84% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 44.86% in the coming year, from $1.07 to $1.55 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -26.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -26.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAvanos Medical has a PEG Ratio of 1.52. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Avanos Medical (NYSE:AVNS) StockAvanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy and OrthogenRx's knee osteoarthritis pain relief injection products. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesSeptember 17, 2023 | americanbankingnews.comCritical Contrast: Avanos Medical (NYSE:AVNS) & OceanTech Acquisitions I (NASDAQ:OTEC)September 12, 2023 | finance.yahoo.comAvanos Medical, Inc. to Present at the CL King Annual Best Ideas ConferenceSeptember 26, 2023 | Legacy Research (Ad)New Cash Law Will Be Disaster for SaversNew law has expert warning seniors and retirees to beware. There's a darker truth behind this financial bombshell...August 11, 2023 | finance.yahoo.comBearish: Analysts Just Cut Their Avanos Medical, Inc. (NYSE:AVNS) Revenue and EPS estimatesAugust 11, 2023 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q2 2023 Earnings Call TranscriptAugust 10, 2023 | markets.businessinsider.comJMP Securities Remains a Hold on Avanos Medical (AVNS)August 10, 2023 | finance.yahoo.comQ2 2023 Avanos Medical Inc Earnings CallAugust 9, 2023 | finance.yahoo.comAvanos Medical, Inc. Announces Second Quarter 2023 ResultsSeptember 26, 2023 | Legacy Research (Ad)New Cash Law Will Be Disaster for SaversNew law has expert warning seniors and retirees to beware. There's a darker truth behind this financial bombshell...August 8, 2023 | finance.yahoo.comAvanos Medical, Inc. to Present at the UBS MedTech, Tools and Genomics Summit 2023August 3, 2023 | finance.yahoo.comAvanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2023 Financial ResultsAugust 1, 2023 | finance.yahoo.comAvanos Medical (NYSE:AVNS) Is Experiencing Growth In Returns On CapitalJuly 24, 2023 | finance.yahoo.comAVNS vs. EW: Which Stock Is the Better Value Option?July 16, 2023 | msn.comAvanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate BuyJuly 3, 2023 | finance.yahoo.comWhat Is Avanos Medical, Inc.'s (NYSE:AVNS) Share Price Doing?June 28, 2023 | finance.yahoo.comAvanos Medical Supports New Interventional Procedure Recommendations from the UK's National Institute of Health and Care Excellence (NICE)June 26, 2023 | bizjournals.comAvanos Medical sells respiratory business for $110M, buys Canadian companyJune 21, 2023 | markets.businessinsider.comAvanos Medical (AVNS) Gets a Hold from JMP SecuritiesJune 20, 2023 | msn.comAvanos agrees to acquire Toronto-based Diros TechnologyJune 19, 2023 | finance.yahoo.comAvanos Medical, Inc. Announces Agreement to Acquire Diros Technology Inc.June 13, 2023 | finance.yahoo.comAvanos Medical, Inc. To Host Investor Day on June 20, 2023June 8, 2023 | markets.businessinsider.comJMP Securities Keeps Their Hold Rating on Avanos Medical (AVNS)June 8, 2023 | finance.yahoo.comMasimo (MASI) Down 6% Since Last Earnings Report: Can It Rebound?June 8, 2023 | msn.comAvanos Medical climbs 7% with the sale of Respiratory Health business to SunMedJune 8, 2023 | markets.businessinsider.comAvanos Medical Divests Respiratory Health Business To SunMedJune 8, 2023 | finance.yahoo.comAvanos Medical, Inc. Announces Sale of Respiratory Health Business to SunMed Group Holdings, LLCJune 7, 2023 | finance.yahoo.comAvanos Medical, Inc.'s (NYSE:AVNS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?See More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Company Calendar Last Earnings8/09/2023Today9/25/2023Next Earnings (Estimated)11/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees4,044Year FoundedN/APrice Target and Rating Average Stock Price Forecast$31.00 High Stock Price Forecast$34.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+52.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.78) Trailing P/E RatioN/A Forward P/E Ratio18.99 P/E Growth1.52Net Income$50.50 million Net Margins-4.61% Pretax Margin5.74% Return on Equity5.49% Return on Assets4.01% Debt Debt-to-Equity Ratio0.16 Current Ratio3.16 Quick Ratio2.23 Sales & Book Value Annual Sales$820 million Price / Sales1.16 Cash Flow$2.72 per share Price / Cash Flow7.47 Book Value$27.77 per share Price / Book0.73Miscellaneous Outstanding Shares46,870,000Free Float45,514,000Market Cap$952.40 million OptionableOptionable Beta0.90 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 57)CEO & Director Comp: $2.37MMr. Michael C. Greiner (Age 50)Sr. VP, CFO & Chief Transformation Officer Comp: $940.45kMs. Mojirade James (Age 56)Sr. VP, Gen. Counsel & Corp. Sec. Comp: $759.53kMr. Kerr W. Holbrook (Age 56)Sr. VP, GM of Chronic Care & Chief Commercial Officer Comp: $716.87kMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSr. VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVP of Strategy & Corp. Devel.John W. CatoVP of HRMr. Lee BurnesSr. VP of Global R&D, Clinical and Medical AffairsMore ExecutivesKey CompetitorsEstablishment LabsNASDAQ:ESTASanara MedTechNASDAQ:SMTIEnovisNYSE:ENOVAgilitiNYSE:AGTIQuanterixNASDAQ:QTRXView All CompetitorsInstitutional OwnershipBarclays PLCSold 4,516 shares on 9/21/2023Ownership: 0.067%Alberta Investment Management CorpBought 3,161 shares on 8/24/2023Ownership: 0.780%Virginia Retirement Systems ET ALBought 19,100 shares on 8/22/2023Ownership: 0.041%Teachers Retirement System of The State of KentuckyBought 816 shares on 8/21/2023Ownership: 0.033%Osaic Holdings Inc.Bought 870 shares on 8/21/2023Ownership: 0.024%View All Institutional Transactions AVNS Stock - Frequently Asked Questions Should I buy or sell Avanos Medical stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares. View AVNS analyst ratings or view top-rated stocks. What is Avanos Medical's stock price forecast for 2023? 3 Wall Street research analysts have issued 12 month target prices for Avanos Medical's stock. Their AVNS share price forecasts range from $28.00 to $34.00. On average, they predict the company's share price to reach $31.00 in the next year. This suggests a possible upside of 52.6% from the stock's current price. View analysts price targets for AVNS or view top-rated stocks among Wall Street analysts. How have AVNS shares performed in 2023? Avanos Medical's stock was trading at $27.06 at the beginning of 2023. Since then, AVNS shares have decreased by 24.9% and is now trading at $20.32. View the best growth stocks for 2023 here. Are investors shorting Avanos Medical? Avanos Medical saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 805,800 shares, an increase of 6.8% from the July 31st total of 754,800 shares. Based on an average daily volume of 255,400 shares, the short-interest ratio is currently 3.2 days. Currently, 1.8% of the company's shares are sold short. View Avanos Medical's Short Interest. When is Avanos Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023. View our AVNS earnings forecast. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) issued its earnings results on Wednesday, August, 9th. The company reported $0.24 earnings per share for the quarter, missing analysts' consensus estimates of $0.34 by $0.10. The firm had revenue of $169.40 million for the quarter, compared to analyst estimates of $186.30 million. Avanos Medical had a negative net margin of 4.61% and a positive trailing twelve-month return on equity of 5.49%. The company's quarterly revenue was down 16.6% on a year-over-year basis. During the same quarter last year, the business earned $0.41 EPS. What ETF holds Avanos Medical's stock ? Invesco S&P SmallCap Health Care ETF holds 119,434 shares of AVNS stock, representing 1.06% of its portfolio. What guidance has Avanos Medical issued on next quarter's earnings? Avanos Medical updated its FY23 earnings guidance on Wednesday, August, 9th. The company provided EPS guidance of $1.05-$1.15 for the period, compared to the consensus earnings per share estimate of $1.52. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), RTX (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA). What is Avanos Medical's stock symbol? Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS." Who are Avanos Medical's major shareholders? Avanos Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (15.64%), Dimensional Fund Advisors LP (6.68%), RGM Capital LLC (5.92%), Paradice Investment Management LLC (4.81%), State Street Corp (4.37%) and Westwood Holdings Group Inc. (3.67%). View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Avanos Medical's stock price today? One share of AVNS stock can currently be purchased for approximately $20.32. How much money does Avanos Medical make? Avanos Medical (NYSE:AVNS) has a market capitalization of $952.40 million and generates $820 million in revenue each year. The company earns $50.50 million in net income (profit) each year or ($0.78) on an earnings per share basis. How many employees does Avanos Medical have? The company employs 4,044 workers across the globe. How can I contact Avanos Medical? Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com. This page (NYSE:AVNS) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.